394 related articles for article (PubMed ID: 32396388)
1. β-Hydroxybutyrate is reduced in humans with obesity-related NAFLD and displays a dose-dependent effect on skeletal muscle mitochondrial respiration in vitro.
Mey JT; Erickson ML; Axelrod CL; King WT; Flask CA; McCullough AJ; Kirwan JP
Am J Physiol Endocrinol Metab; 2020 Jul; 319(1):E187-E195. PubMed ID: 32396388
[TBL] [Abstract][Full Text] [Related]
2. Ketogenic propensity is differentially related to lipid-induced hepatic and peripheral insulin resistance.
Mey JT; Vandagmansar B; Dantas WS; Belmont KP; Axelrod CL; Kirwan JP
Acta Physiol (Oxf); 2023 Dec; 239(4):e14054. PubMed ID: 37840478
[TBL] [Abstract][Full Text] [Related]
3. Relationship between serum β-hydroxybutyrate and hepatic fatty acid oxidation in individuals with obesity and NAFLD.
Moore MP; Shryack G; Alessi I; Wieschhaus N; Meers GM; Johnson SA; Wheeler AA; Ibdah JA; Parks EJ; Rector RS
Am J Physiol Endocrinol Metab; 2024 Apr; 326(4):E493-E502. PubMed ID: 38381399
[TBL] [Abstract][Full Text] [Related]
4. Dissociation between exercise-induced reduction in liver fat and changes in hepatic and peripheral glucose homoeostasis in obese patients with non-alcoholic fatty liver disease.
Cuthbertson DJ; Shojaee-Moradie F; Sprung VS; Jones H; Pugh CJ; Richardson P; Kemp GJ; Barrett M; Jackson NC; Thomas EL; Bell JD; Umpleby AM
Clin Sci (Lond); 2016 Jan; 130(2):93-104. PubMed ID: 26424731
[TBL] [Abstract][Full Text] [Related]
5. Whole-body substrate metabolism is associated with disease severity in patients with non-alcoholic fatty liver disease.
Croci I; Byrne NM; Choquette S; Hills AP; Chachay VS; Clouston AD; O'Moore-Sullivan TM; Macdonald GA; Prins JB; Hickman IJ
Gut; 2013 Nov; 62(11):1625-33. PubMed ID: 23077135
[TBL] [Abstract][Full Text] [Related]
6. Nonalcoholic fatty liver disease is associated with hepatic and skeletal muscle insulin resistance in overweight adolescents.
Deivanayagam S; Mohammed BS; Vitola BE; Naguib GH; Keshen TH; Kirk EP; Klein S
Am J Clin Nutr; 2008 Aug; 88(2):257-62. PubMed ID: 18689359
[TBL] [Abstract][Full Text] [Related]
7. Effect of a ketogenic diet on hepatic steatosis and hepatic mitochondrial metabolism in nonalcoholic fatty liver disease.
Luukkonen PK; Dufour S; Lyu K; Zhang XM; Hakkarainen A; Lehtimäki TE; Cline GW; Petersen KF; Shulman GI; Yki-Järvinen H
Proc Natl Acad Sci U S A; 2020 Mar; 117(13):7347-7354. PubMed ID: 32179679
[TBL] [Abstract][Full Text] [Related]
8. Non-invasive assessment of hepatic lipid subspecies matched with non-alcoholic fatty liver disease phenotype.
Erickson ML; Haus JM; Malin SK; Flask CA; McCullough AJ; Kirwan JP
Nutr Metab Cardiovasc Dis; 2019 Nov; 29(11):1197-1204. PubMed ID: 31371265
[TBL] [Abstract][Full Text] [Related]
9. Cross-talk between branched-chain amino acids and hepatic mitochondria is compromised in nonalcoholic fatty liver disease.
Sunny NE; Kalavalapalli S; Bril F; Garrett TJ; Nautiyal M; Mathew JT; Williams CM; Cusi K
Am J Physiol Endocrinol Metab; 2015 Aug; 309(4):E311-9. PubMed ID: 26058864
[TBL] [Abstract][Full Text] [Related]
10. Skeletal muscle mitochondria exhibit decreased pyruvate oxidation capacity and increased ROS emission during surgery-induced acute insulin resistance.
Hagve M; Gjessing PF; Fuskevåg OM; Larsen TS; Irtun Ø
Am J Physiol Endocrinol Metab; 2015 Apr; 308(8):E613-20. PubMed ID: 25670828
[TBL] [Abstract][Full Text] [Related]
11. Hepatic Insulin Extraction in NAFLD Is Related to Insulin Resistance Rather Than Liver Fat Content.
Utzschneider KM; Kahn SE; Polidori DC
J Clin Endocrinol Metab; 2019 May; 104(5):1855-1865. PubMed ID: 30566676
[TBL] [Abstract][Full Text] [Related]
12. Impaired ketogenesis and increased acetyl-CoA oxidation promote hyperglycemia in human fatty liver.
Fletcher JA; Deja S; Satapati S; Fu X; Burgess SC; Browning JD
JCI Insight; 2019 Apr; 5(11):. PubMed ID: 31012869
[TBL] [Abstract][Full Text] [Related]
13. Reduced skeletal muscle mitochondrial respiration and improved glucose metabolism in nondiabetic obese women during a very low calorie dietary intervention leading to rapid weight loss.
Rabøl R; Svendsen PF; Skovbro M; Boushel R; Haugaard SB; Schjerling P; Schrauwen P; Hesselink MK; Nilas L; Madsbad S; Dela F
Metabolism; 2009 Aug; 58(8):1145-52. PubMed ID: 19454354
[TBL] [Abstract][Full Text] [Related]
14. The role of liver fat and insulin resistance as determinants of plasma aminotransferase elevation in nonalcoholic fatty liver disease.
Maximos M; Bril F; Portillo Sanchez P; Lomonaco R; Orsak B; Biernacki D; Suman A; Weber M; Cusi K
Hepatology; 2015 Jan; 61(1):153-60. PubMed ID: 25145475
[TBL] [Abstract][Full Text] [Related]
15. Associations Among Adipose Tissue Immunology, Inflammation, Exosomes and Insulin Sensitivity in People With Obesity and Nonalcoholic Fatty Liver Disease.
Fuchs A; Samovski D; Smith GI; Cifarelli V; Farabi SS; Yoshino J; Pietka T; Chang SW; Ghosh S; Myckatyn TM; Klein S
Gastroenterology; 2021 Sep; 161(3):968-981.e12. PubMed ID: 34004161
[TBL] [Abstract][Full Text] [Related]
16. Exercise training improves mitochondrial respiration and is associated with an altered intramuscular phospholipid signature in women with obesity.
Mendham AE; Goedecke JH; Zeng Y; Larsen S; George C; Hauksson J; Fortuin-de Smidt MC; Chibalin AV; Olsson T; Chorell E
Diabetologia; 2021 Jul; 64(7):1642-1659. PubMed ID: 33770195
[TBL] [Abstract][Full Text] [Related]
17. Metabolic inflexibility and insulin resistance in obese adolescents with non-alcoholic fatty liver disease.
Lee S; Rivera-Vega M; Alsayed HM; Boesch C; Libman I
Pediatr Diabetes; 2015 May; 16(3):211-8. PubMed ID: 24754380
[TBL] [Abstract][Full Text] [Related]
18. The Novel Adipokine Gremlin 1 Antagonizes Insulin Action and Is Increased in Type 2 Diabetes and NAFLD/NASH.
Hedjazifar S; Khatib Shahidi R; Hammarstedt A; Bonnet L; Church C; Boucher J; Blüher M; Smith U
Diabetes; 2020 Mar; 69(3):331-341. PubMed ID: 31882566
[TBL] [Abstract][Full Text] [Related]
19. Acetoacetate and d- and l-β-hydroxybutyrate have distinct effects on basal and insulin-stimulated glucose uptake in L6 skeletal muscle cells.
Khouri H; Roberge M; Ussher JR; Aguer C
Am J Physiol Cell Physiol; 2024 Jun; 326(6):C1710-C1720. PubMed ID: 38708524
[TBL] [Abstract][Full Text] [Related]
20. Metabolic and histological implications of intrahepatic triglyceride content in nonalcoholic fatty liver disease.
Bril F; Barb D; Portillo-Sanchez P; Biernacki D; Lomonaco R; Suman A; Weber MH; Budd JT; Lupi ME; Cusi K
Hepatology; 2017 Apr; 65(4):1132-1144. PubMed ID: 27981615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
